This includes ABRYSVO® (Respiratory Syncytial Virus Vaccine), which in October 2024 ... free survival – – Vepdegestrant is the first PROTAC degrader to demonstrate clinical benefit in ...

Drugs for metabolic diseases, vaccines, and cancer therapies feature ... which could become the first drug in the PROteolysis Targeting Chimera (PROTAC) class to reach the market.

As winter turned to spring in early 2020, Laura Davis and Tjardus Greidanus were working on a film about vaccines. They were focused on the increasingly politicized debate around them, especially ...

She also receives funding from the Canadian Institutes of Health Research and the Fonds de recherche du Québec to conduct research on vaccine acceptance. Janice E. Graham receives funding from ...

Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding declines by the Trump administration and a drop in biotech funding.

Concerned that the nation’s health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take action to curb their use, a group of public health experts is working ...

Researchers modeled changes in vaccination rates A decrease in current rates could lead to millions of cases Measles was previously considered eradicated in the US Researchers modeled changes in ...

Clinical trials to test vaccine against Alzheimer's-promoting tau protein Date: April 23, 2025 Source: University of New Mexico Health Sciences Center Summary: Researchers hope to launch human ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the ...

Hamburg is former commissioner of the FDA and co-president of the InterAcademy Partnership. Fineberg is president of the Gordon and Betty Moore Foundation and past president of the Institute of ...

Most Americans have encountered false claims about the measles vaccine, and many aren’t sure what the truth is, according to a KFF poll released Wednesday. Misconceptions about measles ...

Kennedy Jr cast doubt on its efficacy. The Novavax vaccine is the only COVID-19 booster in the United States that does not use messenger RNA technology - which some states have begun to ban - and ...